» Articles » PMID: 37576972

Profiles and Diagnostic Value of Intestinal Microbiota in Schizophrenia Patients with Metabolic Syndrome

Overview
Specialty Endocrinology
Date 2023 Aug 14
PMID 37576972
Authors
Affiliations
Soon will be listed here.
Abstract

Aims/hypothesis: It is widely thought that the intestinal microbiota plays a significant role in the pathogenesis of metabolic disorders. However, the gut microbiota composition and characteristics of schizophrenia patients with metabolic syndrome (MetS) have been largely understudied. Herein, we investigated the association between the metabolic status of mainland Chinese schizophrenia patients with MetS and the intestinal microbiome.

Methods: Fecal microbiota communities from 115 male schizophrenia patients (57 with MetS and 58 without MetS) were assessed by 16S ribosomal RNA gene sequencing. We assessed the variations of gut microbiome between both groups and explored potential associations between intestinal microbiota and parameters of MetS. In addition, the Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) based on the KEGG database was used to predict the function of intestinal microbiota. We also conducted Decision Tree Analysis to develop a diagnostic model for the MetS in patients with schizophrenia based on the composition of intestinal microbiota.

Results: The fecal microbial diversity significantly differed between groups with or without MetS (α-diversity (Shannon index and Simpson index): p=0.0155, p=0.0089; β-diversity: p=0.001). Moreover, the microbial composition was significantly different between the two groups, involving five phyla and 38 genera (p<0.05). In addition, a significant correlation was observed between the metabolic-related parameters and abundance of altered microbiota including HDL-c (r2 = 0.203, p=0.0005), GLU (r2 = 0.286, p=0.0005) and WC (r2 = 0.061, p=0.037). Furthermore, KEGG pathway analysis showed that 16 signaling pathways were significantly enriched between the two groups (p<0.05). Importantly, our diagnostic model based on five microorganisms established by decision tree analysis could effectively distinguish between patients with and without MetS (AUC = 0.94).

Conclusions/interpretation: Our study established the compositional and functional characteristics of intestinal microbiota in schizophrenia patients with MetS. These new findings provide novel insights into a better understanding of this disease and provide the theoretical basis for implementing new interventional therapies in clinical practice.

Citing Articles

Should we consider microbiota-based interventions as a novel therapeutic strategy for schizophrenia? A systematic review and meta-analysis.

Hassib L, Kanashiro A, Pedrazzi J, Vercesi B, Higa S, Arruda I Brain Behav Immun Health. 2025; 43():100923.

PMID: 39839986 PMC: 11745983. DOI: 10.1016/j.bbih.2024.100923.


Exploring the effects of probiotics on olanzapine-induced metabolic syndrome through the gut microbiota.

Mushraf S, Chawla K, Fayaz S, Mathew A, Reddy G, Kappettu Gadahad M Gut Pathog. 2024; 16(1):77.

PMID: 39709451 PMC: 11662719. DOI: 10.1186/s13099-024-00664-2.


Unveiling the gut microbiota blueprint of schizophrenia: a multilevel omics approach.

Qi D, Liu P, Wang Y, Tai X, Ma S Front Psychiatry. 2024; 15:1452604.

PMID: 39386896 PMC: 11461293. DOI: 10.3389/fpsyt.2024.1452604.


Altered gut microbiota and systemic immunity in Chinese patients with schizophrenia comorbid with metabolic syndrome.

Ling Z, Lan Z, Cheng Y, Liu X, Li Z, Yu Y J Transl Med. 2024; 22(1):729.

PMID: 39103909 PMC: 11302365. DOI: 10.1186/s12967-024-05533-9.

References
1.
Vogt N, Kerby R, Dill-McFarland K, Harding S, Merluzzi A, Johnson S . Gut microbiome alterations in Alzheimer's disease. Sci Rep. 2017; 7(1):13537. PMC: 5648830. DOI: 10.1038/s41598-017-13601-y. View

2.
Stubbs B, Koyanagi A, Schuch F, Firth J, Rosenbaum S, Gaughran F . Physical Activity Levels and Psychosis: A Mediation Analysis of Factors Influencing Physical Activity Target Achievement Among 204 186 People Across 46 Low- and Middle-Income Countries. Schizophr Bull. 2016; 43(3):536-545. PMC: 5464271. DOI: 10.1093/schbul/sbw111. View

3.
Vasilijevic A, Buzadzic B, Korac A, Petrovic V, Jankovic A, Korac B . Beneficial effects of L-arginine nitric oxide-producing pathway in rats treated with alloxan. J Physiol. 2007; 584(Pt 3):921-33. PMC: 2276988. DOI: 10.1113/jphysiol.2007.140277. View

4.
Bretler T, Weisberg H, Koren O, Neuman H . The effects of antipsychotic medications on microbiome and weight gain in children and adolescents. BMC Med. 2019; 17(1):112. PMC: 6582584. DOI: 10.1186/s12916-019-1346-1. View

5.
Vandeputte D, Falony G, Vieira-Silva S, Tito R, Joossens M, Raes J . Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut. 2015; 65(1):57-62. PMC: 4717365. DOI: 10.1136/gutjnl-2015-309618. View